Rei Tsang Shiao

Array ( [id] => 10007840 [patent_doc_number] => 09051345 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-09 [patent_title] => 'Metalloinsertor complexes targeted to DNA mismatches' [patent_app_type] => utility [patent_app_number] => 13/917447 [patent_app_country] => US [patent_app_date] => 2013-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 89 [patent_no_of_words] => 16330 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13917447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10291010 [patent_doc_number] => 20150176010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-25 [patent_title] => 'H4 RECEPTOR INHIBITORS FOR TREATING TINNITUS' [patent_app_type] => utility [patent_app_number] => 14/405776 [patent_app_country] => US [patent_app_date] => 2013-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 57409 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14405776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10851129 [patent_doc_number] => 08877811 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2014-11-04 [patent_title] => 'Hypoglycemic oral drug for treating non-insulin dependent and insulin dependent diabetes' [patent_app_type] => utility [patent_app_number] => 13/903246 [patent_app_country] => US [patent_app_date] => 2013-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6430 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13903246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10898194 [patent_doc_number] => 08921408 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-30 [patent_title] => 'Compositions comprising an aryl pyrazole and/or a formamidine, methods and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/901077 [patent_app_country] => US [patent_app_date] => 2013-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 39475 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13901077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11230954 [patent_doc_number] => 09458174 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-10-04 [patent_title] => 'Inhibitors of the activity of complex (III) of the mitochondrial electron transport chain and use thereof' [patent_app_type] => utility [patent_app_number] => 14/401685 [patent_app_country] => US [patent_app_date] => 2013-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 13584 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 173 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14401685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9882644 [patent_doc_number] => 08969409 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-03 [patent_title] => 'Treatment for pulmonary hypertension' [patent_app_type] => utility [patent_app_number] => 13/899734 [patent_app_country] => US [patent_app_date] => 2013-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4674 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13899734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9081033 [patent_doc_number] => 20130266563 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-10 [patent_title] => 'SUBSTITUTED 4-(SELENOPHEN-2(OR-3)-YLAMINO)PYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/896538 [patent_app_country] => US [patent_app_date] => 2013-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 31041 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13896538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9295392 [patent_doc_number] => 20140039026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-06 [patent_title] => 'POLYMORPHS AND AMORPHOUS FORMS OF 5-AMINO-1-[2,6-DICHLORO-4-(TRIFLUOROMETHYL)PHENYL]-4-[(TRIFLUOROMETHYL)SULFINYL]-1H-PYRAZOLE-3-CARBONITRILE' [patent_app_type] => utility [patent_app_number] => 13/893045 [patent_app_country] => US [patent_app_date] => 2013-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 7909 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13893045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10528175 [patent_doc_number] => 09254288 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-09 [patent_title] => 'Susceptibility of tumors to tyrosine kinase inhibitors and treatment thereof' [patent_app_type] => utility [patent_app_number] => 13/889337 [patent_app_country] => US [patent_app_date] => 2013-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 11 [patent_no_of_words] => 17721 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13889337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10851088 [patent_doc_number] => 08877769 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-04 [patent_title] => 'Heteroaryl-substituted urea modulators of fatty acid amide hydrolase' [patent_app_type] => utility [patent_app_number] => 13/886857 [patent_app_country] => US [patent_app_date] => 2013-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25611 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13886857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10225749 [patent_doc_number] => 20150110742 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-23 [patent_title] => 'TLR-AGONIST-CONJUGATED ANTIBODY RECRUITING MOLECULES (TLR-ARMS)' [patent_app_type] => utility [patent_app_number] => 14/397995 [patent_app_country] => US [patent_app_date] => 2013-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 22241 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14397995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10044443 [patent_doc_number] => 09084826 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-21 [patent_title] => 'Fatty acid conjugates of statin and FXR agonists; compositions and method of uses' [patent_app_type] => utility [patent_app_number] => 13/874993 [patent_app_country] => US [patent_app_date] => 2013-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22135 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13874993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9042494 [patent_doc_number] => 20130245132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-19 [patent_title] => 'PROCESS FOR PREPARING 4-CYCLOHEXYL-2-METHYL-2-BUTANOL' [patent_app_type] => utility [patent_app_number] => 13/873343 [patent_app_country] => US [patent_app_date] => 2013-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12237 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13873343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9042342 [patent_doc_number] => 20130244980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-19 [patent_title] => 'BORON-CONTAINING SMALL MOLECULES' [patent_app_type] => utility [patent_app_number] => 13/874329 [patent_app_country] => US [patent_app_date] => 2013-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 34948 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13874329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10202663 [patent_doc_number] => 20150087651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-26 [patent_title] => 'PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF BACTERIAL DISEASES' [patent_app_type] => utility [patent_app_number] => 14/397501 [patent_app_country] => US [patent_app_date] => 2013-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19476 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14397501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10202698 [patent_doc_number] => 20150087686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-26 [patent_title] => 'CRYSTALLINE FORMS OF SAXAGLIPTIN' [patent_app_type] => utility [patent_app_number] => 14/396370 [patent_app_country] => US [patent_app_date] => 2013-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10415 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14396370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9662400 [patent_doc_number] => 08809376 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-19 [patent_title] => 'Indanyloxydihydrobenzofuranylacetic acids' [patent_app_type] => utility [patent_app_number] => 13/869144 [patent_app_country] => US [patent_app_date] => 2013-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23955 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13869144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9093727 [patent_doc_number] => 20130273037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-17 [patent_title] => 'COMPOUNDS AND METHODS FOR ANTIVIRAL TREATMENT' [patent_app_type] => utility [patent_app_number] => 13/865069 [patent_app_country] => US [patent_app_date] => 2013-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63299 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13865069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8977340 [patent_doc_number] => 20130210770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'PHARMACEUTICAL FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 13/861846 [patent_app_country] => US [patent_app_date] => 2013-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 63 [patent_figures_cnt] => 63 [patent_no_of_words] => 72528 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13861846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9932165 [patent_doc_number] => 20150080358 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-19 [patent_title] => 'Pharmaceutical Composition' [patent_app_type] => utility [patent_app_number] => 14/389684 [patent_app_country] => US [patent_app_date] => 2013-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4703 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14389684 [rel_patent_id] =>[rel_patent_doc_number] =>)